We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-3.06%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$77.7B
AUM Growth
-$3.9B
Cap. Flow
+$505M
Cap. Flow %
0.65%
Top 10 Hldgs %
24.09%
Holding
3,066
New
55
Increased
1,481
Reduced
1,461
Closed
51

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$83.5M
2
SPGI icon
S&P Global
SPGI
+$73.5M
3
TSLA icon
Tesla
TSLA
+$55.8M
4
MSFT icon
Microsoft
MSFT
+$45.9M
5
AMZN icon
Amazon
AMZN
+$27.9M

Sector Composition

Rank Sector Weight
1 Technology 24.74%
2 Financials 13.53%
3 Healthcare 13.01%
4 Consumer Discretionary 11.66%
5 Industrials 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNR
1526
Core Natural Resources Inc
CNR
$4.45B
$3.54M ﹤0.01%
94,025
+61
+0.1% +$1.77K
RPT
1527
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$3.52M ﹤0.01%
255,921
+3,509
+1% +$45.9K
VGR
1528
DELISTED
Vector Group Ltd.
VGR
$3.52M ﹤0.01%
292,518
-9,514
-3% -$106K
MARA icon
1529
Marathon Digital Holdings
MARA
$3.9B
$3.52M ﹤0.01%
125,819
-10,779
-8% -$280K
HSKA
1530
DELISTED
Heska Corp
HSKA
$3.51M ﹤0.01%
25,409
+2,023
+9% +$286K
SPTN
1531
DELISTED
SpartanNash
SPTN
$3.51M ﹤0.01%
106,334
-1,771
-2% -$50K
KAMN
1532
DELISTED
Kaman Corp
KAMN
$3.5M ﹤0.01%
80,515
+452
+0.6% +$19.1K
BE icon
1533
Bloom Energy
BE
$64.6B
$3.49M ﹤0.01%
144,535
-2,045
-1% -$40K
PATK icon
1534
Patrick Industries
PATK
$2.85B
$3.49M ﹤0.01%
86,781
+5,251
+6% +$242K
NXGN
1535
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$3.49M ﹤0.01%
166,758
-2,706
-2% -$51.8K
OPEN icon
1536
Opendoor
OPEN
$3.38B
$3.48M ﹤0.01%
416,182
-34,143
-8% -$317K
EPAC icon
1537
Enerpac Tool Group
EPAC
$1.93B
$3.48M ﹤0.01%
159,046
+5,129
+3% +$97K
STBA icon
1538
S&T Bancorp
STBA
$1.79B
$3.48M ﹤0.01%
117,573
+262
+0.2% +$8.23K
GIII icon
1539
G-III Apparel Group
GIII
$1.5B
$3.48M ﹤0.01%
128,545
+1,263
+1% +$34.4K
EVH icon
1540
Evolent Health
EVH
$447M
$3.48M ﹤0.01%
107,576
-8,234
-7% -$216K
FATE icon
1541
Fate Therapeutics
FATE
$326M
$3.46M ﹤0.01%
89,382
+758
+0.9% +$29.4K
OTTR icon
1542
Otter Tail
OTTR
$3.94B
$3.45M ﹤0.01%
55,196
-4,692
-8% -$294K
MSGS icon
1543
Madison Square Garden
MSGS
$9.39B
$3.45M ﹤0.01%
19,226
-1,535
-7% -$261K
MGPI icon
1544
MGP Ingredients
MGPI
$375M
$3.45M ﹤0.01%
40,265
-1,204
-3% -$97K
FLGT icon
1545
Fulgent Genetics
FLGT
$527M
$3.44M ﹤0.01%
55,171
+2,115
+4% +$139K
AMSF icon
1546
AMERISAFE
AMSF
$540M
$3.43M ﹤0.01%
69,049
+81
+0.1% +$4.14K
RILY icon
1547
BRC Group Holdings
RILY
$289M
$3.42M ﹤0.01%
48,863
+593
+1% +$40.1K
SCHL icon
1548
Scholastic
SCHL
$792M
$3.41M ﹤0.01%
84,705
+688
+0.8% +$28.5K
BRKL
1549
DELISTED
Brookline Bancorp
BRKL
$3.4M ﹤0.01%
215,203
-5,375
-2% -$90.6K
GLNG icon
1550
Golar LNG
GLNG
$5.13B
$3.38M ﹤0.01%
136,541
-14,565
-10% -$240K

Similar funds

RhumbLine Advisers's Q1 2022 Portfolio in Review

As of Q1 2022, RhumbLine Advisers held 3,066 positions worth $77.7B, down 4.8% from $81.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 3.5%. RhumbLine Advisers opened 55 new positions and exited 51, leaving the 3,066-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2022 buy was Constellation Energy: 528,261 shares worth $29.7M.
  • RhumbLine Advisers added most to Advanced Micro Devices in Q1 2022, an estimated $83.5M increase.
  • RhumbLine Advisers's biggest Q1 2022 reduction was Abbott, cutting an estimated $25.5M.
  • RhumbLine Advisers fully exited Xilinx Inc in Q1 2022, selling an estimated $88.8M.
  • RhumbLine Advisers's ten largest holdings make up 24% of its $77.7B portfolio in Q1 2022.
  • RhumbLine Advisers opened 55 new positions and closed 51 in Q1 2022.
  • RhumbLine Advisers's portfolio value fell 4.8% quarter-over-quarter to $77.7B.

Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.